BCD-055 ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
271	Ankylosing spondylitis	2

46. Malignant rheumatoid arthritis

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02762838 (ClinicalTrials.gov)	January 2016	4/4/2016	Comparative Clinical Trial of Efficacy and Safety of BCD-055and Remicade® in Combination With Methot ...	International Multi-center Comparative Double-blind Randomized Clinical Trial of Efficacy and Safety ...	Rheumatoid Arthritis	Biological: BCD-055;Biological: Remicade®;Drug: Methotrexate;Drug: Folic acid	Biocad	NULL	Completed	18 Years	75 Years	All	426	Phase 3	Belarus;India;Russian Federation

Clinical trials : 563 / Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02762812 (ClinicalTrials.gov)	January 2016	4/4/2016	Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055and Remicade® in Patients With ...	International Multi-center Comparative Double-blind Randomized Clinical Trial to Evaluate Efficacy a ...	Ankylosing Spondylitis	Biological: BCD-055;Biological: Remicade®	Biocad	NULL	Completed	18 Years	65 Years	All	199	Phase 3	Russian Federation
2	NCT02359903 (ClinicalTrials.gov)	February 2015	30/1/2015	Comparative Evaluation of Pharmacokinetics and Safety of BCD-055and Remicade in Patients With Ankylo ...	International Multicenter Comparative Double Blind Study of Pharmacokinetics and Safety of BCD-055an ...	Ankylosing Spondylitis	Drug: Infliximab (BCD-055);Drug: Infliximab (Remicade)	Biocad	NULL	Completed	18 Years	65 Years	All	90	Phase 1	Belarus;Russian Federation